Murchinson’s Ensysce Biosciences ENSC Stock Holding History

Murchinson’s Portfolio ENSC Stock Details ENSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-140,000	Closed	-$358K	–	71
2025 Q1	$358K	Buy	+140,000	New	+$811K	0.02%	74

Other funds holding ENSC

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Murchinson's ENSC Position: Q2 2025 in Review

Murchinson sold out of Ensysce Biosciences (ENSC) in Q2 2025, closing a stake of 140,000 shares — an estimated $358K sold.

Murchinson first reported a position in ENSC in Q1 2025 and held it in 1 quarter. The position peaked at $358K in Q1 2025. 11 funds tracked by Wall St. Rank hold ENSC as of Q2 2025.

Murchinson reported no remaining Ensysce Biosciences position as of Q2 2025 after selling out during the quarter.
Murchinson sold 140,000 Ensysce Biosciences shares in Q2 2025, an estimated $358K.
Murchinson first reported a position in Ensysce Biosciences in Q1 2025 and held it in 1 quarter.
Murchinson's Ensysce Biosciences position peaked at $358K in Q1 2025.
11 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2025.

Based on Murchinson's 13F filing for Q2 2025, filed 14 Aug 2025.